Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review)

Publisher： John Wiley & Sons Inc

E-ISSN： 1530-0277|42|2|238-243

ISSN： 0145-6008

Source： ALCOHOLISM (ELECTRONIC), Vol.42, Iss.2, 2018-02, pp. : 238-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Phosphatidylethanol (PEth) is a direct nonoxidative metabolite of ethanol that may be measured in clinical samples as a marker for monitoring alcohol consumption. It has been used in a wide variety of clinical and nonclinical settings; however, its investigation in relation to liver disease has been limited. This study aims at providing a short review on the applications and challenges for the incorporation of PEth testing in identifying alcohol intake in this patient population.

Related content

Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review

By  

Gerontology, Vol. 60, Iss. 4, 2014-01 ,pp. : 289-293 (5)

Karger

Access to resources Recommend Favorite

Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 997-998 (2)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: depression and the use of anti‐depressants in patients with chronic liver disease or liver transplantation – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 914-915 (2)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: depression and the use of anti‐depressants in patients with chronic liver disease or liver transplantation

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 913-914 (2)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?

By  

HEPATOLOGY, Vol. 62, Iss. 4, 2015-10 ,pp. : 997-998 (2)

John Wiley & Sons Inc

Access to resources Recommend Favorite